Assistant Professor, Medicine - Oncology, Stanford University School of Medicine
Oncology
Dr. Allison W. Kurian, MD
|
|
Give Review
Allison Kurian works in the field of Oncology. He graduated from Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Allison Kurian is a published doctor. He has 40 papers published. The most current publication "Addressing inherited predisposition for breast cancer in transplant recipients." Allison Kurian is registered with Medicare and accepts Medicare payments.
Publications
- Validation of self-reported comorbidity status of breast Cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC).
- Addressing inherited predisposition for breast Cancer in transplant recipients.
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
- Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact.
- Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations.
- Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System.
- Next-generation sequencing for hereditary breast and gynecologic Cancer risk assessment.
- Diabetes and other comorbidities in breast Cancer survival by race/ethnicity: The California Breast Cancer Survivorship Consortium (CBCSC).
- Beyond barriers: fundamental 'disconnects' underlying the treatment of breast Cancer patients' sexual health.
- Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast Cancer in California, 1998-2011.
- A clinical trial of lovastatin for modification of biomarkers associated with breast Cancer risk.
- Breast Cancer treatment across health care systems: Linking Electronic Medical Records and State Registry Data to Enable Outcomes Research.
- The California Breast Density Information Group: A Collaborative Response to the Issues of Breast Density, Breast Cancer Risk, and Breast Density Notification Legislat...
- A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer.
- The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast Cancer survival.
- A young woman with bilateral breast Cancer: identifying a genetic cause and implications for management.
- Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.
- Patterns and predictors of breast Cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.
- Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black-White Crossover.
- A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers.
- Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast Cancer cell lines.
- Patient, Hospital, and Neighborhood Factors Associated with Treatment of Early-Stage Breast Cancer among Asian American Women in California.
- Online Tool to Guide Decisions for BRCA1/2 Mutation Carriers.
- Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry.
- Increasing mastectomy rates for early-stage breast Cancer? Population-based trends from California.
- Survival analysis of Cancer risk reduction strategies for BRCA1/2 mutation carriers.
- Second primary breast Cancer occurrence according to hormone receptor status.
- Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.
- The decline in breast Cancer incidence: real or imaginary?
- Performance of BRCA1/2 mutation prediction models in Asian Americans.
- Magnetic resonance galactography: a feasibility study in women with prior atypical breast Duct cytology.
- A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
- CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric Cancer.
- Ductal pattern enhancement on magnetic resonance imaging of the breast due to Ductal lavage.
- A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast Cancer.
- Cost-effectiveness of screening BRCA1/2 mutation carriers with Breast magnetic resonance imaging.
- Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast Cancer risk.
- Histologic types of epithelial ovarian Cancer: have they different risk factors?
- Breast magnetic resonance image screening and Ductal lavage in women at high genetic risk for breast carcinoma.
Schools
Harvard Medical School
Ma Gen Hospital
Stanford University Med Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Select PPO
- Access Plus Savenet
- Basic Exclusive PPO for Small Business
- Basic PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University School of Medicine -
Stanford University -
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1144385758 | |
| NPPES Provider LastName | KURIAN | |
| NPPES Provider FirstName | ALLISON | |
| NPPES Provider ZIPCode | 943042205 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 90.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144385758 |
| Last Name Of The Provider | KURIAN |
| First Name Of The Provider | ALLISON |
| View All |
Similar Doctors
|
|
Dr. Alice E. Guardino, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel W. Neal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harlan A. Pinto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilbert Chu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arash Alizadeh, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Eric W. Humke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Myron M. Turbow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank E. Stockdale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander D. Colevas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jody C. Chuang, MD |